Predicted to enable oxidoreductase activity and zinc ion binding activity. Is expressed in several structures, including body wall mesenchyme; central nervous system; limb mesenchyme; peripheral nervous system ganglion; and trigeminal nerve. Orthologous to human VAT1L (vesicle amine transport 1 like). [provided by Alliance of Genome Resources, Apr 2022]